SRS exposure leads to increased mitochondrial fission and decreased fusion, i.e., excessive increase in MTFP1, and activation of the mTOR pathway causes PTSD-like symptoms, while the combination of suvorexant and mTOR can improve mitochondrial dynamics. The gene discussed is MTFP1; the disease is post-traumatic stress disorder.